Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX7 | Q99572 | 1/20 | 0.55 |
| ▸ | NOTUM | Q6P988 | 3/20 | 0.53 |
| ▸ | MAOA | P21397 | 1/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.53 |
| ▸ | DRD2 | P14416 | 2/20 | 0.45 |
| ▸ | DRD4 | P21917 | 2/20 | 0.45 |
| ▸ | DRD3 | P35462 | 2/20 | 0.45 |
| ▸ | ESRRA | P11474 | 1/20 | 0.42 |
| ▸ | CD74 | P04233 | 1/20 | 0.41 |
| ▸ | MIF | P14174 | 1/20 | 0.41 |
| ▸ | CA12 | O43570 | 2/20 | 0.41 |
| ▸ | CA1 | P00915 | 2/20 | 0.41 |
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | CA9 | Q16790 | 2/20 | 0.41 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.40 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.40 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.40 |
| ▸ | KDM1A | O60341 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5675088 | 0.98 | P2RX7 (0.53) | P2RX7NOTUMMAOAL3MBTL1DRD2 | |
| SCHEMBL2889068 | 0.74 | P2RX7 (0.55) | P2RX7NOTUMMAOAL3MBTL1DRD2 | |
| SCHEMBL12959177 | 0.74 | P2RX7 (0.55) | P2RX7NOTUMMAOAL3MBTL1DRD2 | |
| SCHEMBL17039112 | 0.74 | P2RX7 (0.55) | P2RX7NOTUMMAOAL3MBTL1DRD2 | |
| SCHEMBL12443625 | 0.74 | P2RX7 (0.55) | P2RX7NOTUMMAOAL3MBTL1DRD2 | |
| SCHEMBL23028378 | 0.74 | NOTUM (0.58) | P2RX7NOTUMMAOAL3MBTL1DRD2 | |
| SCHEMBL16090354 | 0.74 | P2RX7 (0.55) | P2RX7NOTUMMAOAL3MBTL1DRD2 | |
| SCHEMBL6030190 | 0.74 | NOTUM (0.58) | P2RX7NOTUMMAOAL3MBTL1DRD2 | |
| SCHEMBL2629357 | 0.74 | P2RX7 (0.55) | P2RX7NOTUMMAOAL3MBTL1DRD2 | |
| SCHEMBL2358990 | 0.74 | P2RX7 (0.55) | P2RX7NOTUMMAOAL3MBTL1DRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8518478-B2 | Conductive fibers and a method of manufacturing the same | INKTEC CO., LTD. (KR) | 2013-08-27 | — | — | US | claimed |
| US-20110003153-A1 | CONDUCTIVE FIBERS AND A METHOD OF MANUFACTURING THE SAME | INKTEC CO., LTD. (KP) | 2011-01-06 | — | — | US | claimed |
| WO-2008103013-A1 | CONDUCTIVE FIBERS AND A METHOD OF MANUFACTURING THE SAME | INKTEC CO., LTD. (KR) | 2008-08-28 | — | — | WO | claimed |
| US-11389456-B2 | Compounds and methods for treating oxalate-related diseases | OXALURX, INC. (US) | 2022-07-19 | — | — | US | disclosed |
| US-20200390778-A1 | COMPOUNDS AND METHODS FOR TREATING OXALATE-RELATED DISEASES | OXALURX, INC. | 2020-12-17 | — | — | US | disclosed |
| WO-2019165159-A1 | COMPOUNDS AND METHODS FOR TREATING OXALATE-RELATED DISEASES | OXALURX, INC. (US) | 2019-08-29 | — | — | WO | disclosed |
| US-8518478-B2 | Conductive fibers and a method of manufacturing the same | INKTEC CO., LTD. (KR) | 2013-08-27 | — | — | US | disclosed |
| EP-2413696-A1 | COMPOSITIONS FOR TREATMENT OF ALZHEIMER'S DISEASE | Mount Sinai School Of Medicine Of New York University (US) | 2012-02-08 | — | — | EP | disclosed |
| US-20110003153-A1 | CONDUCTIVE FIBERS AND A METHOD OF MANUFACTURING THE SAME | INKTEC CO., LTD. (KP) | 2011-01-06 | — | — | US | disclosed |
| WO-2010114636-A1 | COMPOSITIONS FOR TREATMENT OF ALZHEIMER'S DISEASE | MOUNT SINAI SCHOOL OF MEDICINE OF NEW YORK UNIVERSITY (US) | 2010-10-07 | — | — | WO | disclosed |
| WO-2008103013-A1 | CONDUCTIVE FIBERS AND A METHOD OF MANUFACTURING THE SAME | INKTEC CO., LTD. (KR) | 2008-08-28 | — | — | WO | disclosed |
| US-6756191-B2 | LIGHT-SENSITIVITY AND EXCELLENT STORAGE STABILITY | KONICA CORPORATION (JP) | 2004-06-29 | — | — | US | disclosed |
| US-20030157447-A1 | Silver halide photographic light-sensitive emulsion and silver halide photographic light-sensitive material using thereof | KONICA CORPORATION (JP) | 2003-08-21 | — | — | US | disclosed |
| EP-1283439-A1 | Silver halide photographic light-sensitive emulsion and silver halide photographic light-sensitive material | Konica Corporation (JP) | 2003-02-12 | — | — | EP | disclosed |
| EP-0712036-B1 | Silver halide light-sensitive photographic screen-film system with enhanced image quality for rapid processing applications in mammography | AGFA GEVAERT NV (BE) | 1999-07-28 | — | — | EP | disclosed |
| EP-0712036-A1 | Silver halide light-sensitive photographic screen-film system with enhanced image quality for rapid processing applications in mammography | AGFA-GEVAERT N.V. (BE) | 1996-05-15 | — | — | EP | disclosed |
| EP-0610609-A1 | Silver halide light-sensitive photographic material with enhanced image quality for rapid processing applications in mammography | AGFA-GEVAERT N.V. (BE) | 1994-08-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200390778-A1 | COMPOUNDS AND METHODS FOR TREATING OXALATE-RELATED DISEASES | XDH, PNPO, LOX | P2RX7 2313/4885NOTUM 1065/4885MAOA 110/4885 |
| US-11389456-B2 | Compounds and methods for treating oxalate-related diseases | XDH, PNPO, LOX | P2RX7 2313/4885NOTUM 1065/4885MAOA 110/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.